HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN. XALATAN® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 INDICATIONS AND USAGEXALATAN is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. (1) DOSAGE AND ADMINISTRATIONOne drop in the affected eye(s) once daily in the evening. (2) DOSAGE FORMS AND STRENGTHSOphthalmic solution containing latanoprost 50 mcg/mL (0.005%). (3) CONTRAINDICATIONSKnown hypersensitivity to latanoprost, benzalkonium chloride or any other ingredients in this product. (4) WARNINGS AND PRECAUTIONSADVERSE REACTIONSMost common adverse reactions (5–15%) from clinical trials are blurred vision, burning and stinging, conjunctival hyperemia, foreign body sensation, itching, increased pigmentation of the iris, and punctate keratitis. (6) To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. See 17 for PATIENT COUNSELING INFORMATION. Revised: 9/2020 |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
XALATAN®(latanoprost)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
XALATAN® Quick Finder
Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.